Profil bibliographique

Sadie Roberts

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées

262Citations signalées

3Affiliations récentes

Institutions déclarées

University of Leeds Leeds Trinity University Cancer Research UK Clinical Trials Unit

Domaines associés

Multiple Myeloma Research and TreatmentsCancer Treatment and PharmacologyProtein Degradation and InhibitorsChronic Lymphocytic Leukemia ResearchMultiple Sclerosis Research Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial

Martin Kaiser, Rachel Phillip, Sarah Brown, Amy Holroyd et autres

0 citationsThe Lancet Oncology

Accès ouvert 2026 articleOpenAlex

Clinical and immunological effects of adding cyclophosphamide to pomalidomide–dexamethasone in relapsed‐refractory multiple myeloma: The randomized MUKseven trial

Andrew Hall, James Croft, Katrina Walker, Kevin Boyd et autres

0 citationsBritish Journal of Haematology

Accès ouvert 2026 articleOpenAlex

Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data

Lesley Smith, Janice Hoang, Sharon Gillson, Jeanine Richards et autres

0 citationsBMJ Open

2025 conference-abstractOpenAlex

Can a patient questionnaire (VRAT) reduce the need for ocular examinations with less frequent belantamab mafodotin combined with bortezomib and dexamethasone? the ukmra prommise d trial

Rakesh Popat, Robert Cicero, Andrew Hall, Alexandra Welsh et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study

Sam Keaveney, Damien J. McHugh, Mihaela Rata, Alina Dragan et autres

2 citationsBritish Journal of Radiology

2024 conference-paperOpenAlex

A repository-integrated tool for monitoring imaging protocol compliance in a multi-centre whole-body MRI myeloma study

Sam Keaveney, Damien J. McHugh, Mihaela Rata, Alina Dragan et autres

0 citationsProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

Accès ouvert 2024 conference-abstractOpenAlex

Extended Intensified Consolidation and Maintenance Improve Ultra High-Risk Multiple Myeloma Patient Outcome - Long-Term Follow-up of the Ukmra Optimum/Muknine Trial

Martin Kaiser, Andrew Hall, Rachel Phillip, Amy Holroyd et autres

2 citationsBlood

Accès ouvert 2024 conference-abstractOpenAlex

Belantamab Mafodotin Plus Cyclophosphamide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Interim Results from the UK Myeloma Research Alliance Prommise Clinical Trial

Rakesh Popat, Charlotte Pawlyn, Robert Cicero, Andrew Hall et autres

3 citationsBlood

2023 conference-abstractOpenAlex

Ultra High-Risk Multiple Myeloma Patients with Multi-Hit Tumours and SKY92 High Risk Signature Are at Increased Risk of Early Relapse Even When Treated with Extended Intensified Induction and Consolidation - Results from the Optimum/Muknine Trial

Martin Kaiser, Rachel Phillip, Andrew Hall, Amy Holroyd et autres

8 citationsBlood

Accès ouvert 2023 articleOpenAlex

Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study

Sam Keaveney, Alina Dragan, Mihaela Rata, Matthew Blackledge et autres

15 citationsInsights into Imaging

2023 conference-paperOpenAlex

Image quality in MY-RADS whole-body MRI protocols applied in a prospective multi-centre multiple myeloma study

Sam Keaveney, Alina Dragan, Mihaela Rata, Matthew Blackledge et autres

Accès ouvert 2023 articleOpenAlex

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

Martin Kaiser, Andrew Hall, Katrina Walker, Amy L. Sherborne et autres

117 citationsJournal of Clinical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.